Speech delivered by Laura d’Arrigo, Chair of the EMCDDA Management Board, on the launch of the European Drug Report 2021
Since early 2020, the COVID-19 pandemic has had a dramatic impact on the way in which we live. Countries in Europe, and around the world, have had to introduce unprecedented measures to protect public health.
What are the lessons to be learnt from the European Drug Report 2021?
The new EU Drugs Strategy 2021–25 makes explicit that the European response to drugs should be evidence-based and delivered through a balanced and integrated approach, which ultimately must be judged on its impact on the health, safety and wellbeing of our citizens.